Literature DB >> 8519470

Tolerance of Staphylococcus epidermidis grown from indwelling vascular catheters to antimicrobial agents.

N Khardori1, M Yassien, K Wilson.   

Abstract

During a prospective study of indwelling vascular catheter-related infections, 134 isolates of Staphylococcus epidermidis were grown from 700 catheter tips. In vitro antimicrobial susceptibility testing of these isolates to oxacillin, vancomycin and ofloxacin was performed using the standard broth microdilution technique. These results were compared to those for the same organisms grown in biofilm before the addition of antimicrobial agents. In 96-well flat bottom microtiter plates, 10(4)-10(5) colony forming units of S. epidermidis in 0.1 ml broth were grown for 18 h at 37 degrees C, at which time a biofilm was observed for all isolates. Different concentrations of antimicrobial agents (0.1 ml) were then added to the plates. The plates were incubated for 18 h at 37 degrees C. Since MICs could not be estimated in these plates, all the wells were subcultured after mixing the biofilm with the broth. Minimum bactericidal concentrations (MBCs) were defined as 99.9% reduction in colony forming units. For organisms grown in suspension, 100% of the isolates were susceptible to vancomycin, 81% to ofloxacin and 40% to oxacillin. MBCs of susceptible isolates were within four-fold differences for vancomycin (53%), oxacillin (50%), and ofloxacin (51%). When grown as a biofilm, 78%, 93% and 71% of isolates had MBCs of > or = 2048 micrograms ml-1 of oxacillin, vancomycin and ofloxacin respectively. These data demonstrate the reduced bactericidal activity of antimicrobial agents against S. epidermidis in a biofilm and a simple method for its detection in the microbiology laboratory.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8519470     DOI: 10.1007/BF01569818

Source DB:  PubMed          Journal:  J Ind Microbiol        ISSN: 0169-4146


  32 in total

Review 1.  Testing the susceptibility of bacteria in biofilms to antibacterial agents.

Authors:  H Anwar; M K Dasgupta; J W Costerton
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

Review 2.  Infections associated with indwelling devices: concepts of pathogenesis; infections associated with intravascular devices.

Authors:  G M Dickinson; A L Bisno
Journal:  Antimicrob Agents Chemother       Date:  1989-05       Impact factor: 5.191

3.  Antibiotic resistance of biomaterial-adherent coagulase-negative and coagulase-positive staphylococci.

Authors:  P T Naylor; Q N Myrvik; A Gristina
Journal:  Clin Orthop Relat Res       Date:  1990-12       Impact factor: 4.176

4.  Usefulness of a test for slime production as a marker for clinically significant infections with coagulase-negative staphylococci.

Authors:  D S Davenport; R M Massanari; M A Pfaller; M J Bale; S A Streed; W J Hierholzer
Journal:  J Infect Dis       Date:  1986-02       Impact factor: 5.226

Review 5.  Bacterial biofilms in nature and disease.

Authors:  J W Costerton; K J Cheng; G G Geesey; T I Ladd; J C Nickel; M Dasgupta; T J Marrie
Journal:  Annu Rev Microbiol       Date:  1987       Impact factor: 15.500

6.  The penetration of antibiotics into aggregates of mucoid and non-mucoid Pseudomonas aeruginosa.

Authors:  W W Nichols; M J Evans; M P Slack; H L Walmsley
Journal:  J Gen Microbiol       Date:  1989-05

7.  Major trends in the microbial etiology of nosocomial infection.

Authors:  D R Schaberg; D H Culver; R P Gaynes
Journal:  Am J Med       Date:  1991-09-16       Impact factor: 4.965

8.  Staphylococcus epidermidis extracted slime inhibits the antimicrobial action of glycopeptide antibiotics.

Authors:  B F Farber; M H Kaplan; A G Clogston
Journal:  J Infect Dis       Date:  1990-01       Impact factor: 5.226

9.  Prospective study of infections in indwelling central venous catheters using quantitative blood cultures.

Authors:  D Benezra; T E Kiehn; J W Gold; A E Brown; A D Turnbull; D Armstrong
Journal:  Am J Med       Date:  1988-10       Impact factor: 4.965

10.  Comparative in vitro antibiotic resistance of surface-colonizing coagulase-negative staphylococci.

Authors:  A G Gristina; R A Jennings; P T Naylor; Q N Myrvik; L X Webb
Journal:  Antimicrob Agents Chemother       Date:  1989-06       Impact factor: 5.191

View more
  11 in total

1.  Vancomycin-resistant Enterococcus faecium: catheter colonization, esp gene, and decreased susceptibility to antibiotics in biofilm.

Authors:  Issam I Raad; Hend A Hanna; Maha Boktour; Gassan Chaiban; Ray Y Hachem; Tanya Dvorak; Russell Lewis; Barbara E Murray
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

2.  Heterogeneously vancomycin-resistant Staphylococcus epidermidis strain causing recurrent peritonitis in a dialysis patient during vancomycin therapy.

Authors:  K Sieradzki; R B Roberts; D Serur; J Hargrave; A Tomasz
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

3.  Enzymatic removal and disinfection of bacterial biofilms.

Authors:  C Johansen; P Falholt; L Gram
Journal:  Appl Environ Microbiol       Date:  1997-09       Impact factor: 4.792

Review 4.  Strategic Moves of "Superbugs" Against Available Chemical Scaffolds: Signaling, Regulation, and Challenges.

Authors:  Bikash Baral; M R Mozafari
Journal:  ACS Pharmacol Transl Sci       Date:  2020-04-13

5.  Thiazolidione derivatives targeting the histidine kinase YycG are effective against both planktonic and biofilm-associated Staphylococcus epidermidis.

Authors:  Ren-zheng Huang; Li-kang Zheng; Hua-yong Liu; Bin Pan; Jian Hu; Tao Zhu; Wei Wang; Dan-bin Jiang; Yang Wu; You-cong Wu; Shi-qing Han; Di Qu
Journal:  Acta Pharmacol Sin       Date:  2012-01-09       Impact factor: 6.150

Review 6.  Staphylococcus epidermidis--the 'accidental' pathogen.

Authors:  Michael Otto
Journal:  Nat Rev Microbiol       Date:  2009-08       Impact factor: 60.633

7.  In vitro activity of vancomycin, quinupristin/dalfopristin, and linezolid against intact and disrupted biofilms of staphylococci.

Authors:  Mohamed El-Azizi; Suma Rao; Termkiat Kanchanapoom; Nancy Khardori
Journal:  Ann Clin Microbiol Antimicrob       Date:  2005-01-07       Impact factor: 3.944

8.  A combination of silver nanoparticles and visible blue light enhances the antibacterial efficacy of ineffective antibiotics against methicillin-resistant Staphylococcus aureus (MRSA).

Authors:  Fatma Elzahraa Akram; Tarek El-Tayeb; Khaled Abou-Aisha; Mohamed El-Azizi
Journal:  Ann Clin Microbiol Antimicrob       Date:  2016-08-17       Impact factor: 3.944

9.  Efficacy of ultraviolet C light at sublethal dose in combination with antistaphylococcal antibiotics to disinfect catheter biofilms of methicillin-susceptible and methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis in vitro.

Authors:  Mohamed El-Azizi; Nancy Khardori
Journal:  Infect Drug Resist       Date:  2016-08-19       Impact factor: 4.003

10.  Distinct Phenotypic and Genomic Signatures Underlie Contrasting Pathogenic Potential of Staphylococcus epidermidis Clonal Lineages.

Authors:  Diana Espadinha; Rita G Sobral; Catarina Inês Mendes; Guillaume Méric; Samuel K Sheppard; João A Carriço; Hermínia de Lencastre; Maria Miragaia
Journal:  Front Microbiol       Date:  2019-08-27       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.